Remove Collective Remove Extraction Remove Pharmaceutical
article thumbnail

Papa’s Herb® Enters the Oregon Market Through Halo Collective

Cannabis Law Report

TORONTO , July 19, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a brand licensing arrangement (the “Licensing Agreement”) with Brezwald Corp. Related Links.

article thumbnail

Italian Ministry of Health has publishes guidelines for the extraction of active ingredients

Cannabis Law Report

The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S. The Ministry of Health, at our request, has made public the authorization procedure for the manufacture of cannabis extracts on its portal .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. regulators plan hearing on growing use of CBD in products

Cannabis Chronicles

regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. People have been drawn to the extract because of its supposed calming effects. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders.

CBD 113
article thumbnail

Thailand: Chulalongkorn University Taps into Medical Cannabis and Expands the Product Line

Cannabis Law Report

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

article thumbnail

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership

Cannabis Law Report

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

Thailand: Press Release Thailand Govt Pharma Organization “Pharmaceutical Organization, Department of Medical Cooperation, Research on Medical Marijuana Extracts For cancer patients with neurodegenerative epilepsy And nervous pain”

Cannabis Law Report

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.